ASKOVU Trademark

Trademark Overview

On Friday, April 26, 2019, a trademark application was filed for ASKOVU with the United States Patent and Trademark Office. The USPTO has given the ASKOVU trademark a serial number of 88404754. The federal status of this trademark filing is REGISTERED as of Tuesday, December 20, 2022. This trademark is owned by Gilead Sciences Ireland UC. The ASKOVU trademark is filed in the Pharmaceutical Products category with the following description:

Antiviral pharmaceutical preparations; anti-infective pharmaceutical preparations; anti-fibrotic pharmaceutical preparations; pharmaceutical preparations for treatment and prevention of HIV infection; pharmaceutical preparations for the treatment of liver diseases and disorders; pharmaceutical preparations for the treatment of hematological diseases and disorders; pharmaceutical preparations for the treatment of oncological diseases and disorders; pharmaceutical preparations for the treatment of inflammatory diseases and disorders; pharmaceutical preparations for the treatment of autoimmune diseases and disorders; pharmaceutical preparations for the treatment of respiratory and pulmonary diseases and disorders; pharmaceutical preparations for the treatment of kidney and nephropathic diseases and disorders; pharmaceutical preparations for the treatment of arthritis
askovu

General Information

Serial Number88404754
Word MarkASKOVU
Filing DateFriday, April 26, 2019
Status700 - REGISTERED
Status DateTuesday, December 20, 2022
Registration Number6927097
Registration DateTuesday, December 20, 2022
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 22, 2019

Trademark Statements

Goods and ServicesAntiviral pharmaceutical preparations; anti-infective pharmaceutical preparations; anti-fibrotic pharmaceutical preparations; pharmaceutical preparations for treatment and prevention of HIV infection; pharmaceutical preparations for the treatment of liver diseases and disorders; pharmaceutical preparations for the treatment of hematological diseases and disorders; pharmaceutical preparations for the treatment of oncological diseases and disorders; pharmaceutical preparations for the treatment of inflammatory diseases and disorders; pharmaceutical preparations for the treatment of autoimmune diseases and disorders; pharmaceutical preparations for the treatment of respiratory and pulmonary diseases and disorders; pharmaceutical preparations for the treatment of kidney and nephropathic diseases and disorders; pharmaceutical preparations for the treatment of arthritis

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, May 16, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGilead Sciences Ireland UC
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressCarrigtohill, Co. Cork
IE
Party NameGilead Sciences Ireland UC
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressCarrigtohill, Co. Cork
IE
Party NameGilead Sciences Ireland UC
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressCarrigtohill, Co. Cork
IE

Trademark Events

Event DateEvent Description
Tuesday, December 20, 2022NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, December 20, 2022REGISTERED-PRINCIPAL REGISTER
Thursday, November 17, 20221(B) BASIS DELETED; PROCEED TO REGISTRATION
Wednesday, November 16, 2022NOTICE OF ALLOWANCE CANCELLED
Wednesday, November 16, 2022TEAS DELETE 1(B) BASIS RECEIVED
Wednesday, May 18, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, May 17, 2022SOU EXTENSION 5 GRANTED
Wednesday, May 11, 2022SOU EXTENSION 5 FILED
Tuesday, May 17, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, May 11, 2022TEAS EXTENSION RECEIVED
Thursday, November 4, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, November 2, 2021SOU EXTENSION 4 GRANTED
Tuesday, November 2, 2021SOU EXTENSION 4 FILED
Tuesday, November 2, 2021TEAS EXTENSION RECEIVED
Wednesday, April 21, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, April 19, 2021SOU EXTENSION 3 GRANTED
Monday, April 19, 2021SOU EXTENSION 3 FILED
Monday, April 19, 2021TEAS EXTENSION RECEIVED
Thursday, October 22, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, October 20, 2020SOU EXTENSION 2 GRANTED
Tuesday, October 20, 2020SOU EXTENSION 2 FILED
Tuesday, October 20, 2020TEAS EXTENSION RECEIVED
Wednesday, April 22, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, April 20, 2020SOU EXTENSION 1 GRANTED
Monday, April 20, 2020SOU EXTENSION 1 FILED
Monday, April 20, 2020TEAS EXTENSION RECEIVED
Tuesday, December 17, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 22, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 22, 2019PUBLISHED FOR OPPOSITION
Wednesday, October 2, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, September 17, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, August 28, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, August 28, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, August 27, 2019ASSIGNED TO LIE
Monday, August 19, 2019TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Monday, July 15, 2019NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Monday, July 15, 2019LETTER OF SUSPENSION E-MAILED
Monday, July 15, 2019SUSPENSION LETTER WRITTEN
Monday, July 8, 2019ASSIGNED TO EXAMINER
Thursday, May 16, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, April 30, 2019NEW APPLICATION ENTERED IN TRAM

Related Keywords

askovu preparations pharmaceutical treatment disorders diseases anti respiratory autoimmune pulmonary kidney